ASX 200 rises, API soars, Wesfarmers up

The ASX 200 rose today. There was a takeover offer for API.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) rose by 0.8% today to 7,334 points.

Here are some of the highlights from the ASX:

Wesfarmers Ltd (ASX: WES) offer for Australian Pharmaceutical Industries Ltd (ASX: API)

Wesfarmers announced today a non-binding, indicative proposal to buy the entire API business.

This offer was a 21% premium to API's last closing price.

API's largest shareholder, Washington H. Soul Pattinson and Co Ltd (ASX: SOL), which owns 19.3% of API, has agreed to vote in favour of the proposal and has granted a call option in respect of its API shares in favour of Wesfarmers.

Wesfarmers said it's well positioned to bring capital and unique capabilities to support investment that will strengthen the competitive position of API and its community pharmacy partners.

The Wesfarmers managing director Rob Scott said:

If the proposal is successful, API would form the basis of a new healthcare division of Wesfarmers and a base from which to invest and develop capabilities in the health and wellbeing sector.

The combination of Wesfarmers and API is a compelling opportunity to capitalise on API's strengths and positioning in these markets while drawing upon Wesfarmers' capabilities in retail and distribution, our strong balance sheet and our willingness to invest in our businesses for growth over the long-term.

API's board pointed out that the offer has been made at a time when COVID-19 restrictions have resulted in store and clinic closures and these have significantly affected operational performance. The board is undertaking an analysis on whether the offer is reflective of the long-term growth prospects of API and the expected short-term impacts of the pandemic lockdown restrictions.

Indeed, in a trading update that was also released today, it said that lockdowns in the current form beyond the end of July would impact profit by approximately $1 million of earnings before interest and tax (EBIT) per week of extension.

API is now expecting that its full year underlying EBIT will be in between $66 million to $68 million and its reported EBIT to be in the range of $31 million and $33 million.

The company also said that the build of its new Marsden Park distribution centre in north-west Sydney, at a cost of $50 million, remains on time and within budget. That automated distribution centre is expected to deliver a 20% improvement in cost per unit with annualised savings of around $8 million at the earnings before interest, tax, depreciation and amortisation (EBITDA) level, flowing from the start of FY23.

Healius Ltd (ASX: HLS)

The Healius share price rose slightly today. It announced an acquisition.

It is buying Axis Diagnostics, which the ASX 200 company described as a high-quality Queensland-based imaging business with EBITDA of approximately $2 million, consisting of three radiology practices located in growth areas near Brisbane and one practice in the Whitsundays.

Healius managing director and CEO Dr Malcolm Parmenter said:

The acquisition is in line with our business' network optimisation strategy, has been funded from cash and is earnings per share accretive. It complements and extends our existing footprint, grows revenue and capabilities, and deliver synergies with our facilities and national contracts.

Motley Fool contributor Tristan Harrison owns shares of Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Washington H. Soul Pattinson and Company Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares finished the trading week on a high this Friday.

Read more »

A businessman stacks building blocks.
Technology Shares

6% gain! What's up with Block shares today?

Block shares are up more than 34% since 2 May.

Read more »

Broker looking at the share price.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today

These shares are having a strong finish to the week. But why?

Read more »

A woman puts her hands up as she smashes and breaks through a glass ceiling.
Share Gainers

How these 5 ASX 200 stocks are smashing the benchmark this week

These fives ASX 200 stocks have made some very happy shareholders this week. Here’s how.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Catalyst Metals, Duratec, Nufarm, and Rio Tinto shares are dropping today

These shares are ending the week in the red. But why?

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

After its strategy day, what does Macquarie think Wesfarmers shares are worth?

Let's see what the broker is saying about this blue chip.

Read more »